Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors in cancer therapy: advances and perspectives

Current Pharmaceutical Design
Mengzhu XueHonglin Li

Abstract

The insulin-like growth factors (IGF) and their receptors play pivotal roles in cellular signaling transduction and thus regulate cell growth, differentiation, apoptosis, transformation and other important physiological progresses. The insulin-like growth factor 1 receptor (IGF-1R) mainly engages in the Ras/mitogen-activated protein kinase (MAPK) pathway and the phosphoinositide 3-kinase/protein kinase B (PI3K/AKT) pathway, and also forms cross-talk with the epidermal growth factor receptor (EGFR) pathway. Currently, it draws more attention since its overexpression has been demonstrated in various human cancers, such as colorectal cancer, breast cancer, prostate cancer and lung tumors, thus the strategy targeting the IGF-1R would be promising in treatment of these cancers. There are already dozens of agents developed for the inhibition of IGF-1R, which are categorized into monoclonal antibodies, small molecule inhibitors and so on. While in this review, small molecule inhibitors would be the focus for detailed discussion. Herein, we updated previously reported research papers and reviews in this field and summarized developments of small molecule inhibitors up to 2011. Finally, we proposed the application of network pharmacolog...Continue Reading

Citations

Nov 14, 2013·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Lin WangHongchen Liu
Apr 23, 2013·Cellular Signalling·Luqing ZhaoYa Cao
Mar 2, 2016·Theoretical Biology & Medical Modelling·Nicolas CarelsJack Adam Tuszynski
Sep 8, 2015·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Mee-Young AhnJung-Hoon Yoon
Dec 24, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Na LiJin He
Jul 22, 2015·Current Opinion in Chemical Biology·Zan Chen, Philip A Cole
Apr 14, 2015·BioMed Research International·Varsha P BrahmkhatriHanudatta S Atreya
Feb 6, 2018·Molecular Biology Reports·Irem Dogan TuracliYaren Sari
Jan 1, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Tie-Feng ZhangJi-Quan Chen
Nov 30, 2018·Journal of Cellular Physiology·Saeed NoorolyaiBehzad Baradaran
Sep 26, 2020·International Journal of Molecular Sciences·Soo-Im ChoiIn-Gyu Kim
Nov 24, 2016·Apoptosis : an International Journal on Programmed Cell Death·Tarik GhadbanYogesh K Vashist
May 23, 2021·Human Immunology·Elham BaghbaniBehzad Baradaran

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis